John Foy & Associates is pleased to announce the recipient of the Strong Arm Leukemia Scholarship.

ATLANTA, GA, October 08, 2019 /24-7PressRelease/ — John Foy & Associates proudly announces its 2019 Strong Arm Leukemia recipient, Onyekaorise Chigbogwu of Independence, Mo. Chigbogwu, 18, is a freshman at Northwestern University in Evanston, IL.

At John Foy & Associates, one of Atlanta’s largest personal injury law firms, we recognize a fighter when we see one. Chigbogwu has transformed his medical battle into an inspirational career choice that can help others. He joins a growing list of Foy & Associates Strong Arm Leukemia Scholarship recipients.

He wants to continue raising awareness as a professional. “I want to study communications or journalism so I can, through writing and photography, educate others on the fight against cancer,” he wrote.

His powerful essay describes his transformative battle with leukemia that began at age 11 and ended four years later. He was admitted into the intensive care unit at Children’s Mercy Hospital in Kansas City, MO., Oct. 23, 2012.

Like many families, his parents and siblings’ lives were irrevocably altered. His father, Godwin, had two jobs and quit one to be available for his son. Mother, Franka, quit her job. His brother and two sisters rallied to his side as well, and the family of six relied on one income.

Chigbogwu recovered and persevered, eventually becoming the chair of the American Cancer Society’s Relay for Life in Jackson County, Mo. He became an inspirational speaker for fundraisers, as well.

He wrote in his essay: “In large-scale meetings, I often take a poll: ‘Raise your hand if you or someone you know has been affected by cancer.'”

Inevitably, every hand went up.

John Foy & Associates began its Strong Arm Leukemia Scholarship in 2015 because “we know that every battle isn’t won in a courtroom.” Recipients are awarded $1,000 and must be enrolled in a college or university and have been affected by cancer. For more information, go to our website, or call us at (404) 400-4000.

For the original version of this press release, please visit here